CClinicalTrials.gg
SuspendedNCT03337256Updated Apr 9, 2020

Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy

An interventional study of GI bleeding score in Upper Gastrointestinal Bleeding, sponsored by Chinese University of Hong Kong. Suspended at 2 sites in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-09.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
762
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Acute upper gastrointestinal bleeding (UGIB) is a common cause for attendance to the Emergency Department with a wide range of clinical severity, ranging from insignificant to life-threatening. While there is robust data to support the benefit of upper endoscopy within 24 hours of admission, the implementation of early upper endoscopy while patients are still in the emergency room has not been widely accepted due to lack of added benefit in terms of patient outcome such as mortality and re-bleeding rate. However, the use of upper endoscopy in the emergency room with the purpose of facilitating early discharge of low risk patients with upper gastrointestinal bleeding has not been studied.

Read the detailed description

The Glasgow Blatchford Score (GBS) was developed in 2000 to identify very low risk patients who would not need any intervention and were of low risk of rebleeding and death. The GBS used objective clinical parameters that could be easily obtained in the emergency department and did not use any endoscopy findings as parameters. Unlike the Rockall score which was designed to identify high risk patients, the GBS was used to identify low risk patients who could be safely discharged from the emergency department without endoscopy and studies have shown it to be superior in this regard. The main limitation of GBS is its low specificity with only 4-8% of all patients presenting with upper gastrointestinal bleeding stratified as low risk. Furthermore, the GBS was derived from a Scottish gastrointestinal bleeding registry and may not be applicable to the local population.

Suitable patients attending the Accident \& Emergency Department for symptoms of upper gastrointestinal bleeding will be identified and recruited by the Accident \& Emergency physicians. Patients presenting to Endoscopy Centre after admission will also be recruited to collect clinical data.

Univariate analysis was carried out on the development set using Pearson's chi-square method to examine the association among the factors on the outcome. Variables significantly associated with 30 day re-attendance rate in univariate analyses (P\<=0.1) will be entered in multivariate logistic regression models. Risk factors which retained significance in multivariate analyses will be selected for incorporation into the risk score. A weighting will be assigned to each independent variable in the risk score, applying the corresponding adjusted odds ratio (AOR). The risk score for each subject is the sum of all the risk factors. To evaluate the predictive ability of the scoring system, a receiver operating characteristic (ROC) curve was constructed and the area under the curve (AUC) was delineated. A concordance (c)-statistics was used to reflect the discriminative ability of the prediction tool.

Cost-effective economical model will be used in cost effective analysis of the use of early discharge strategy.

02

Conditions studied

  • Upper Gastrointestinal Bleeding
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients attending either the Prince of Wales Hospital or Alice Ho Miu Ling Nethersole hospital with symptoms of upper gastrointestinal bleeding will be initially resuscitated and stabilized in the Accident \& Emergency Department (AED) as per local practice

Exclusion criteria

Exclusion Criteria:

  1. Incapable of providing informed consent
  2. Age \<18 years old
  3. Pregnancy
  4. Medically unfit to receive an upper endoscopy procedure (require O2 supplement >3L/min, persistent haemodynamic instability despite initial resuscitation, mental confusion)
  5. Require admission to intensive care unit
  6. Require emergency endoscopy for uncontrolled gastrointestinal bleeding
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
762 participants (estimated)

Study arms

  • Experimental
    GI bleeding score

    Early endoscopy in emergency department + other clinical parameters

    Diagnostic Test: GI bleeding score

Interventions

  • Diagnostic testGI bleeding score

    Risk factor Score component value Age (years) 15-29 -2 30-44 -1.5 45-59 0 60-74 1.5 * 75 2.5 Haemoglobin(g/L) * 10.0 0 \<9.9 2 Systolic blood pressure (mmHg) * 110 0 90-109 1.5 \<90 2.5 Pulse (beats per min) \<100 0 * 100 1.5 Creatinine (mmol/L) \<200 0 * 200 3.5 Number of blood transfusion 0 0 1 1.5 * 2 2 Presenting symptom Melaena -1.5 Drug treatment Acid blcoking drug 1.5 anticoagulant 3 Endoscopy findings Clean-based ulcer -2 SRH or blood in stomach 4 Varices 5

05

What researchers measure

Primary outcomes

  1. Re-attendance rate to emergency department

    re-attendance rate to emergency department for upper gastrointestinal bleeding

    Time frame: 30-day

Secondary outcomes

  1. Mortality rate

    all-cause mortality rate

    Time frame: 30-day

  2. Re-attendance rate to emergency department

    all cause re-attendance to emergency department for upper gastrointestinal bleeding

    Time frame: 30-day

  3. Length of hospital stay

    Number of days of hospitalization

    Time frame: 30-day

  4. Need for further medical intervention

    Need for further medical intervention both before and after the first upper endoscopy

    Time frame: 30-day

06

Study locations

2 sites
  • Alice Ho Miu Ling Nethersole Hospital
    Hong Kong, Hong Kong
  • Prince of Wales Hospital
    Hong Kong, Hong Kong
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03337256
Lead sponsor
Chinese University of Hong Kong
Responsible party
Aric Josun Hui (Conultant-in-charge, Combined Endoscopy Unit, Alice Ho Miu Ling Nethersole Hospital, Chinese University of Hong Kong) — Principal investigator
First posted
Nov 8, 2017
Start date
Sep 1, 2015
Primary completion
Aug 31, 2025 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Apr 9, 2020

Study contacts

Aric Josun Hui, MD
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion